These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6129159)

  • 1. The biology of schizophrenia.
    Crow TJ
    Experientia; 1982 Nov; 38(11):1275-82. PubMed ID: 6129159
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical effects of the isomers of flupenthixol--the consequences of dopamine receptor blockade in acute schizophrenia [proceedings].
    Crow TJ; Frith C; Johnstone EC
    Br J Clin Pharmacol; 1977 Oct; 4(5):648P. PubMed ID: 911634
    [No Abstract]   [Full Text] [Related]  

  • 3. A report on the use of flupenthixol in the maintenance treatment of psychotic patients at Ibadan, Nigeria.
    Jegede RO; Ibazebo H
    Afr J Psychiatry; 1981; 7(1-2):21-4. PubMed ID: 6122369
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluphenazine and flupenthixol decanoate in psychiatric outpatients practice.
    Coufal J; Novotný M
    Act Nerv Super (Praha); 1981 Dec; 23(4):269-71. PubMed ID: 6121439
    [No Abstract]   [Full Text] [Related]  

  • 5. [Schizophrenia and dopamine (author's transl)].
    Toru M
    Tanpakushitsu Kakusan Koso; 1978; 23(4):303-16. PubMed ID: 26107
    [No Abstract]   [Full Text] [Related]  

  • 6. Note on an abnormality of the operator for the structural gene of the dopamine D1 receptor as a possible partial cause of schizophrenia.
    Wassermann GD
    J Theor Biol; 1986 Jun; 120(3):277-83. PubMed ID: 2878120
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereochemical specificity in the antipsychotic effects of flupenthixol in man [proceedings].
    Crow TJ; Johnstone EC
    Br J Pharmacol; 1977 Mar; 59(3):466P. PubMed ID: 14758
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopaminergic mechanisms in schizophrenia: the antipsychotic effect and the disease process.
    Crow TJ; Johnstone EC; Longden AJ; Owen F
    Life Sci; 1978 Aug; 23(6):563-7. PubMed ID: 29195
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical aspects of schizophrenia.
    Lewis ME
    Essays Neurochem Neuropharmacol; 1980; 4():1-67. PubMed ID: 6104597
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine and schizophrenia.
    Crow TJ; Johnstone EC; Longden A; Owen F
    Adv Biochem Psychopharmacol; 1978; 19():301-9. PubMed ID: 29450
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of antipsychotic effect in treatment of acute schizophrenia.
    Meltzer HY
    Lancet; 1978 May; 1(8074):1151-2. PubMed ID: 77438
    [No Abstract]   [Full Text] [Related]  

  • 12. Skin conductance responsivity during acute episodes of schizophrenia as a predictor of symptomatic improvement.
    Frith CD; Stevens M; Johnstone EC; Crow TJ
    Psychol Med; 1979 Feb; 9(1):101-6. PubMed ID: 424477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
    Ehmann TS; Delva NJ; Beninger RJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
    Kong DS; Yeo SH
    Singapore Med J; 1985 Dec; 26(7):551-5. PubMed ID: 3834613
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine receptors and schizophrenia.
    Reynolds GP
    Biochem Soc Trans; 1996 Feb; 24(1):202-5. PubMed ID: 8674664
    [No Abstract]   [Full Text] [Related]  

  • 16. Flupenthixol decanoate--in treatment of out-patients.
    Gottfries CG; Green L
    Acta Psychiatr Scand Suppl; 1974; 255():15-24. PubMed ID: 4533707
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of flupenthixol on the clinical state and EEG recordings in schizoprenics].
    Ekiert H; Gogol Z; Welbel L
    Psychiatr Pol; 1977; 11(1):7-14. PubMed ID: 847055
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathophysiology of schizophrenia: dopamine hypothesis.
    Neylan TC
    J Neuropsychiatry Clin Neurosci; 1996; 8(2):222. PubMed ID: 9081562
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurotransmitters and CNS disease. Schizophrenia.
    Snyder SH
    Lancet; 1982 Oct; 2(8305):970-4. PubMed ID: 6127468
    [No Abstract]   [Full Text] [Related]  

  • 20. [Schizophrenia as a dopamine excess syndrome].
    Toru M
    Nihon Rinsho; 1983 May; 41(5):1021-7. PubMed ID: 6138444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.